Teva Pharmaceutical Industries Limited (
) will begin trading ex-dividend on February 20, 2014. A cash
dividend payment of $0.34 per share is scheduled to be paid on
March 10, 2014. Shareholders who purchased TEVA stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
represents an 4.29% increase over the prior quarter.
The previous trading day's last sale of TEVA was $45.67,
representing a -1.97% decrease from the 52 week high of $46.59 and
a 25.95% increase over the 52 week low of $36.26.
TEVA is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). TEVA's current earnings per share, an indicator of a company's
profitability, is $1.5. Zacks Investment Research reports TEVA's
forecasted earnings growth in 2014 as -9.46%, compared to an
industry average of 9%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to TEVA through an Exchange
Traded Fund [ETF]?
The following ETF(s) have TEVA as a top-10 holding:
- iShares MSCI Israel Capped Investable Market Index Fund (
- iShares MSCI ACWI ex US Healthcare ETF (
- Guggenheim Defensive Equity ETF (
- First Trust Value Line Dividend Index Fund (
The top-performing ETF of this group is AXHE with an increase of
8.29% over the last 100 days. EIS has the highest percent weighting
of TEVA at 25%.